Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy
Clinical trial NCT04149821 · TERMINATED
Trial details
- NCT number
- NCT04149821
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-10
- Primary completion
- 2022-01-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.